by Weill Cornell Medical College Illustration of the complex structure of S1P1, siponimod, and the Gi protein. The structure gives insights into how the drug activates the receptor. Credit: Dr. Xin-Yun Huang Investigators from Weill Cornell Medicine and Memorial Sloan Kettering Cancer Center have discovered how a drug for multiple sclerosis interacts with its targets, a finding that may...
